LISA best strategy to prevent chronic lung disease in preterm infants

A new study compared seven different ventilation strategies. Based on data collected from 30 different trials and over 5,500 infants younger than 33 weeks' gestational age. LISA, or Less Invasive Surfactant Administration (on Continuous Positive Airway Pressure) was the best in preventing the primary outcome of death and/or chronic lung disease as well as other secondary outcomes including severe intraventricular hemorrhage and air leak.